PFM
HUMAW icon

Privium Fund Management’s Humacyte Inc Warrant HUMAW Stock Holding History

Privium Fund Management’s Portfolio HUMAW Stock Details HUMAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26,550
Closed -$44.1K – 100
2024
Q2 		$44.1K Buy
+26,550
New +$32.9K 0.01% 103

Other funds holding HUMAW

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Privium Fund Management's HUMAW Position: Q3 2024 in Review

Privium Fund Management sold out of Humacyte Inc Warrant (HUMAW) in Q3 2024, closing a stake of 26,550 shares — an estimated $44.1K sold.

Privium Fund Management first reported a position in HUMAW in Q2 2024 and held it in 1 quarter. The position peaked at $44.1K in Q2 2024. 7 funds tracked by Wall St. Rank hold HUMAW as of Q3 2024.

  • Privium Fund Management reported no remaining Humacyte Inc Warrant position as of Q3 2024 after selling out during the quarter.
  • Privium Fund Management sold 26,550 Humacyte Inc Warrant shares in Q3 2024, an estimated $44.1K.
  • Privium Fund Management first reported a position in Humacyte Inc Warrant in Q2 2024 and held it in 1 quarter.
  • Privium Fund Management's Humacyte Inc Warrant position peaked at $44.1K in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Humacyte Inc Warrant as of Q3 2024.

Based on Privium Fund Management's 13F filing for Q3 2024, filed 1 Nov 2024.